A carregar...
A post-incorporation study on the use of palivizumab in the Brazilian public health system
Respiratory syncytial virus (RSV) is the main cause of lower respiratory disease in infants and children under five years of age. As there is no specific treatment for RSV infections, prophylaxis with the specific monoclonal antibody palivizumab (PVZ) has been widely recommended for high-risk cases...
Na minha lista:
| Publicado no: | Rev Inst Med Trop Sao Paulo |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Instituto de Medicina Tropical
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7845933/ https://ncbi.nlm.nih.gov/pubmed/33533808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1678-9946202163005 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|